Cereno Scientific AB (publ) (STO:CRNO.B)
4.886
-0.074 (-1.49%)
At close: Aug 14, 2026
Cereno Scientific AB Market Cap
Cereno Scientific AB has a market cap or net worth of 1.52 billion as of August 14, 2026. Its market cap has decreased by -42.07% in one year.
Market Cap
1.52B
Enterprise Value
1.63B
Revenue
66.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.89
ChartMarket Cap Chart
Since June 22, 2016, Cereno Scientific AB's market cap has increased from 68.69M to 1.52B, an increase of 2,119.89%. That is a compound annual growth rate of 35.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.52B | -26.10% |
| Dec 30, 2025 | 2.06B | 33.18% |
| Dec 30, 2024 | 1.55B | 44.86% |
| Dec 29, 2023 | 1.07B | 244.90% |
| Dec 30, 2022 | 310.10M | -42.01% |
| Dec 30, 2021 | 534.73M | 553.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.35B |
| Nanexa AB | 854.64M |
| Dicot Pharma AB | 709.69M |
| EQL Pharma AB | 679.18M |
| Cinclus Pharma Holding AB | 562.18M |
| Moberg Pharma AB | 535.81M |
| Orexo AB | 507.06M |
| Enzymatica AB | 459.98M |